Human CXCL10/IP-10 DuoSet ELISA DY266-05 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman CXCL10/IP-10 DuoSet ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $450.00Supplier Page View Company Product Page
Catalog NumberDY266-05
Quantity1 Kit (for 5 Plates) (also 1 Kit (for 15 Plates))
ApplicationsELISA
Detection Range31.20 - 2000 pg/mL
ReactivityHuman
Detection TargetCXCL10/IP-10/CRG-2
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene NameC-X-C motif chemokine ligand 10
NCBI Gene AliasesC7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) The Hippo terminal effector YAP boosts enterovirus replication in type 1 diabetesNat CommunOctober 6, 2025Shirin Geravandi, Huan Liu, Heena Pahwa, Murali Krishna Madduri, Farah Atawneh, Adib Miraki Feriz, Sahar Rafizadeh, Annabelle Elisabeth Kruf, Mona Khazaei, Pouria Bahrami, et al.controls and virus infected isolated human islets was measured by Human CXCL10/IP-10 DuoSet ELISA kit (#DY266-05, R&D Systems, MN, USA) according to the manufacturer’s instructions. qPCR analysis Total RNA was isolated

(2) Estrogen induces the alternative activation of macrophages through binding to estrogen receptor-alphaExperimental and molecular pathologySeptember 1, 2025Belboul A, Ashworth J, Fadel A, Mcloughlin J, Mahmoud A, El Mohtadi M.

(3) TET2 has endothelial-specific roles in interferon responses that are dysregulated by hyperglycemia in vitro and in vivoThe Journal of biological chemistrySeptember 1, 2025Green HLH, Sum H, Sinha P, Visnagri A, Lee SH, Baffour-Kyei A, Lee H, Santos F, Theofilatos K, Brewer AC.determined with ELISA kits purchased from R&D systems (Human CXCL9/MIG, #DY392-05; Human CXCL10/IP-10, #DY266-05; Human CXCL11/I-TAC, #DY672). Cell supernatants were diluted 1:8 and the assays were carried out according

(4) Combining mucosal microbiome and host multi-omics data shows prognostic potential in paediatric ulcerative colitisNature communicationsAugust 4, 2025Kulecka M, O'Sullivan J, Fitzgerald R, Velikonja A, Huseyin CE, Laserna-Mendieta EJ, Ruiz-Limón P, Eckenberger J, Vidal-Marín M, Truppel BA, et al.

(5) Investigating the Immunogenic Potential of Variations in Host Cell Protein Levels in Clinical-Grade AAV8 ProductsInvest Ophthalmol Vis SciJune 11, 2025Immanuel P. Seitz, Eduardo Rodríguez-Bocanegra, Kirsten Bucher, Felix F. Reichel, Stylianos Michalakis, Dimitri Romanovsky, Martin Biel, Bernd Wissinger, Karl-Ulrich Bartz-Schmidt, Tobias Peters, et al.cytokines in response to AAV8 vector lots was measured using cytokine-specific sandwich-ELISA kits (cat. DY266-05, DY271-05, DY208-05 [R&D Systems, MN, USA] and cat. 555212 [BD Biosciences]) according to the manufacturer's

(6) Physiologically relevant coculture model for oral microbial-host interactionsInt J Oral SciMay 27, 2025Zeyang Pang, Nicole M. Cady, Lujia Cen, Thomas M. Schmidt, Xuesong He, Jiahe Liassay All apical chamber solutions were analyzed directly by Human CXCL10/IP-10 DuoSet ELISA kit (DY266-05, R&D Systems, Minneapolis, MN, USA). All operations were performed according to the kit protocol instructions.

(7) Pro-Inflammatory Properties of Salivary Gland-Derived Fibroblasts-Implications in Sjögren's DiseaseCellsApril 8, 2025Brunner M, Guggisberg D, Sprecher M, Pastva O, Bürki K, Houtman M, Kreuzer M, Krättli SA, Jahnke L, Roceri M, et al.

(8) Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxBlood cancer journalFebruary 2, 2025Coughlin CA, Chahar D, Lekakis M, Youssfi AA, Li L, Roberts E, Gallego NC, Volmar CH, Landgren O, Brothers S, et al.

(9) SMARCA4 regulates the NK-mediated killing of senescent cellsScience advancesJanuary 17, 2025Reen V, D'Ambrosio M, Søgaard PP, Tyson K, Leeke BJ, Clément I, Dye ICA, Pombo J, Kuba A, Lan Y, et al.

(10) Molluscum contagiosum virus protein MC089 inhibits interferon regulatory factor 3 activationJournal of General VirologyAugust 21, 2024Mariya Al Hamrashdi, Carla Sanchez Perez, Darya A. Haas, Jyoti Vishwakarma, Andreas Pichlmair, Andrew G. Bowie, Gareth BradyCdCl2-induced MEP4-MC089 HEK293T cells were assayed for IP-10/CXCL10 with an ELISA kit (R and D Systems # DY266-05) according to the manufacturer’s protocol. Optical density was measured at 450 nm using a Thermo Scientific

(11) Neutrophil extracellular traps promote immunopathogenesis of virus-induced COPD exacerbationsNature communicationsJuly 9, 2024Katsoulis O, Toussaint M, Jackson MM, Mallia P, Footitt J, Mincham KT, Meyer GFM, Kebadze T, Gilmour A, Long M, et al.

(12) Myocardial transcriptomic analysis of diabetic patients with aortic stenosis: key role for mitochondrial calcium signalingCardiovascular diabetologyJuly 8, 2024Cherpaz M, Meugnier E, Seillier G, Pozzi M, Pierrard R, Leboube S, Farhat F, Vola M, Obadia JF, Amaz C, et al.

(13) Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathwaysNature communicationsMay 15, 2024Kurmasheva N, Said A, Wong B, Kinderman P, Han X, Rahimic AHF, Kress A, Carter-Timofte ME, Holm E, van der Horst D, et al.

(14) Association of the Reduced Levels of Monocyte Chemoattractant Protein-1 with Herpes Zoster in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors in a Single-Center CohortMicroorganismsMay 12, 2024Chen PK, Chen YM, Chen HH, Liao TL, Chang SH, Yeo KJ, Huang PH, Chen DY.

(15) Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancerNature communicationsApril 12, 2024Wang Y, Pattarayan D, Huang H, Zhao Y, Li S, Wang Y, Zhang M, Li S, Yang D.

(16) Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariantsNature microbiologyFebruary 1, 2024Reuschl AK, Thorne LG, Whelan MVX, Ragazzini R, Furnon W, Cowton VM, De Lorenzo G, Mesner D, Turner JLE, Dowgier G, et al.

(17) Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girlsPloS oneJanuary 1, 2024Nasr MA, Aldous A, Daniels J, Joy C, Capozzi E, Yang M, Moriarty P, Emmanuel-Baker V, Malcolm S, Green SJ, et al.

(18) FBXO21 mediated degradation of p85α regulates proliferation and survival of acute myeloid leukemiaLeukemiaNovember 1, 2023Dobish KK, Wittorf KJ, Swenson SA, Bean DC, Gavile CM, Woods NT, Ghosal G, Hyde RK, Buckley SM.

(19) Development of cyclopeptide inhibitors of cGAS targeting protein-DNA interaction and phase separationNature communicationsOctober 2, 2023Wang X, Wang Y, Cao A, Luo Q, Chen D, Zhao W, Xu J, Li Q, Bu X, Quan J.kits for human IFNβ levels (R&D Systems, Cat# DY814-05) and human CXCL10 levels (R&D Systems, Cat# DY266-05) according to the manufacturer’s instructions. Mice serum was collected and analyzed by ELISA kits for

(20) Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacyMolecular therapy. Nucleic acidsJune 13, 2023McKenzie C, El-Kholy M, Parekh F, Robson M, Lamb K, Allen C, Sillibourne J, Cordoba S, Thomas S, Pule M.

Be the First to Write a Review!

Human CXCL10/IP-10 DuoSet ELISA

CXCL10/IP-10/CRG-2 ELISA

CXCL10/IP-10/CRG-2 ELISA

Human CXCL10/IP-10 DuoSet ELISA from R&D Systems, a Bio-Techne Brand

R&D Systems, a Bio-Techne Brand

Citations (129)

Reviews

Human CXCL10/IP-10 DuoSet ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map